Our latest bronchiectasis initiative is designed to move learning beyond a single encounter. See what years of experience have taught us: rebrand.ly/9541CM #Bronchiectasis #Pulmonology

HER2 (ERBB2) mutations are uncommon in NSCLC but they can carry important treatment implications. Explore case-based CME on testing, NGS interpretation, and treatment selection in HER2-mutant mNSCLC. rebrand.ly/9489OSM

Specialized audience, complex science, and strong engagement. Our collaboration with @ImmunologyAAI demonstrates what can happen when immunology expertise, clinical relevance, and thoughtful educational design come together in GPP. Read the story: rebrand.ly/9483CM

Previous TFF bronchiectasis education has reached thousands of clinicians. But every successful initiative also teaches us something. See how those insights are informing the next chapter of our education: rebrand.ly/9541CM #Bronchiectasis #MedEd #CME

Last chance! Complete our interactive activity on optimizing corticosteroid use in #DMD and earn CE credit before it expires October 30: rebrand.ly/9470SM

Outcomes don’t just tell us what worked; they can reveal what clinicians need next. See how early results from our GPP initiative are informing the ongoing educational opportunity in this rare disease. rebrand.ly/9483CM #MedEd #GPP #RareDisease

Shared decision making starts with listening. Practice obesity conversations and receive personalized feedback with CaseCoach: rebrand.ly/9454CCSM

The approach to treating bronchiectasis is evolving, and education must evolve with it. See how TFF is building on years of experience to address changing science, persistent clinical gaps, and emerging approaches to care. rebrand.ly/9541CM #Bronchiectasis #Pulmonology

How do corticosteroids fit into today's evolving #DMD treatment landscape? Explore practical strategies for integrating corticosteroids with gene therapy and other emerging treatments. Only available until Oct. 30: rebrand.ly/9470SM

From IL-36 signaling to clinical decision-making, our collaboration with @ImmunologyAAI helps clinicians translate evolving immunology in GPP into practical approaches to recognition, targeted therapy, and management. Explore the impact: rebrand.ly/9483CM #GPP

Bronchiectasis education isn’t new territory for TFF. We’ve worked with pulmonary experts and institutions for years to address evolving needs in bronchiectasis care. Now, we’re building on that experience once again. Read more: rebrand.ly/9541CM #Bronchiectasis #MedEd

What role does shared decision making play in obesity care? Explore practical strategies in our interactive publication: rebrand.ly/9454IASM

As precision medicine evolves, education plays a critical role in bringing new science into everyday clinical practice. Read more: rebrand.ly/JXCM #CME #PrecisionMedicine #HealthcareInnovation

Strong partnerships create stronger education. Our collaboration with @isth has already achieved over half of its learner engagement goal with months still to go, helping clinicians prepare for the future of secondary stroke prevention. Read more: rebrand.ly/9481CM

Reaching learners is one thing, keeping them engaged is another. The overwhelming majority of learners of our GPP education reported not only a better understanding of this rare disease, but also a commitment to making meaningful changes in their practice. rebrand.ly/9483CM

Individualizing corticosteroid therapy is becoming increasingly important in #DMD care. Explore the latest evidence through our free interactive activity: rebrand.ly/9470SM

Accurate interpretation drives better care. Explore the evidence supporting race-neutral PFT recommendations in our free CE activity: rebrand.ly/9460SM #Pulmonology #ATS #PFT

Partnerships drive progress. Our latest article explores how collaboration between scientific leaders and education providers helps clinicians keep pace with precision medicine. rebrand.ly/JXCM #HealthcareEducation #Genomics

Education works best when it's designed around real clinical challenges. Learn how The France Foundation and @isth are helping neurologists prepare for emerging therapies in secondary stroke prevention. rebrand.ly/9481CM #Neurology #MedicalEducation

A rare disease doesn't mean a small educational need. Our GPP education with @ImmunologyAAI is helping clinicians connect evolving IL-36 science with diagnosis, treatment, and patient care and early engagement is strong. Read more: rebrand.ly/9483CM #GPP #RareDisease